Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew C. Chan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Scott Moore - $250K in CRVS purchases and sales in the last 12 months
- Richard A. Md Miller - $83K in CRVS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew C. Chan?
Andrew C. Chan is a corporate insider of Corvus Pharmaceuticals, Inc. (CRVS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Andrew C. Chan last file a Form 4?
The only primary Form 4 on record is dated 27 April 2026.